| Website | transpharma-medic... |
| Category | BioTech |
| Phone | 972-8-9152201 |
| Employees | |
| Founded | 2000 |
| TOTAL | $18M |
| VENTURE FUNDING TOTAL | $18M |
| Series C, 7/06 Argonaut Private Equity Pitango Venture Capital Evergreen Venture Partners Teva Pharmaceutical Industries T2C2 Capital Biomedical Investments TIF Ventures Pte | $18M |
TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug-products utilizing an innovative active transdermal drug delivery technology. Their current proprietary drug-product development programs include ViaDerm-hPTH (1-34), a transdermal hPTH (1-34) product to treat osteoporosis, undergoing Phase 2B clinical trials, which is developed in collaboration with Eli Lilly, and two additional peptides currently in Phase 1.
